Literature DB >> 21916656

Protection against malaria by MSP3 candidate vaccine.

Sodiomon B Sirima, Simon Cousens, Pierre Druilhe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21916656     DOI： 10.1056/NEJMc1100670

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  38 in total

Review 1.  Vaccines for malaria: how close are we?

Authors:  Mahamadou A Thera; Christopher V Plowe
Journal:  Annu Rev Med       Date:  2011-11-10       Impact factor: 13.739

2.  Immunogenicity and antigenicity of Plasmodium vivax merozoite surface protein 10.

Authors:  Yang Cheng; Bo Wang; Jetsumon Sattabongkot; Chae Seung Lim; Takafumi Tsuboi; Eun-Taek Han
Journal:  Parasitol Res       Date:  2014-04-25       Impact factor: 2.289

3.  Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2.

Authors:  Jean Claude Dejon-Agobe; Ulysse Ateba-Ngoa; Albert Lalremruata; Andreas Homoet; Julie Engelhorn; Odilon Paterne Nouatin; Jean Ronald Edoa; José F Fernandes; Meral Esen; Yoanne Darelle Mouwenda; Eunice M Betouke Ongwe; Marguerite Massinga-Loembe; Stephen L Hoffman; B Kim Lee Sim; Michael Theisen; Peter G Kremsner; Ayôla A Adegnika; Bertrand Lell; Benjamin Mordmüller
Journal:  Clin Infect Dis       Date:  2019-09-27       Impact factor: 9.079

Review 4.  Malaria vaccines since 2000: progress, priorities, products.

Authors:  Patrick E Duffy; J Patrick Gorres
Journal:  NPJ Vaccines       Date:  2020-06-09       Impact factor: 7.344

5.  Current status of malaria vaccines.

Authors:  Deepak Gaur; Virander S Chauhan
Journal:  Indian J Pediatr       Date:  2013-04-19       Impact factor: 1.967

Review 6.  Vaccines to Accelerate Malaria Elimination and Eventual Eradication.

Authors:  Julie Healer; Alan F Cowman; David C Kaslow; Ashley J Birkett
Journal:  Cold Spring Harb Perspect Med       Date:  2017-09-01       Impact factor: 6.915

7.  Immunization with the MAEBL M2 Domain Protects against Lethal Plasmodium yoelii Infection.

Authors:  Juliana A Leite; Daniel Y Bargieri; Bruna O Carvalho; Letusa Albrecht; Stefanie C P Lopes; Ana Carolina A V Kayano; Alessandro S Farias; Wan Ni Chia; Carla Claser; Benoit Malleret; Bruce Russell; Catarina Castiñeiras; Leonilda M B Santos; Marcelo Brocchi; Gerhard Wunderlich; Irene S Soares; Mauricio M Rodrigues; Laurent Rénia; Fabio T M Costa
Journal:  Infect Immun       Date:  2015-07-13       Impact factor: 3.441

8.  Sequential processing of merozoite surface proteins during and after erythrocyte invasion by Plasmodium falciparum.

Authors:  Michelle J Boyle; Christine Langer; Jo-Anne Chan; Anthony N Hodder; Ross L Coppel; Robin F Anders; James G Beeson
Journal:  Infect Immun       Date:  2013-11-11       Impact factor: 3.441

9.  Plasmodium falciparum MSP3 Exists in a Complex on the Merozoite Surface and Generates Antibody Response during Natural Infection.

Authors:  Arunaditya Deshmukh; Bishwanath Kumar Chourasia; Sonali Mehrotra; Ikhlaq Hussain Kana; Gourab Paul; Ashutosh Panda; Inderjeet Kaur; Susheel Kumar Singh; Sumit Rathore; Aparup Das; Priya Gupta; Md Kalamuddin; S K Gakhar; Asif Mohmmed; Michael Theisen; Pawan Malhotra
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

10.  Inhibitory humoral responses to the Plasmodium falciparum vaccine candidate EBA-175 are independent of the erythrocyte invasion pathway.

Authors:  Aida S Badiane; Amy K Bei; Ambroise D Ahouidi; Saurabh D Patel; Nichole Salinas; Daouda Ndiaye; Ousmane Sarr; Omar Ndir; Niraj H Tolia; Souleymane Mboup; Manoj T Duraisingh
Journal:  Clin Vaccine Immunol       Date:  2013-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.